Pemvidutide Pemvidutide, another weekly GLP-1/glucagon dual agonist, is under evaluation in the ongoing phase 2 IMPACT trial (NCT05989711) in 190 individuals with histologically confirmed MASH and fibrosis stages F2-F3 [47]
How does this compare to actual HGH injections
This can be a challenge if youre on a GLP-1, like Ozempic, due to a reduced appetite
For members, the picture is no better: side effects with limited clinical guidance, and the quiet assumption that staying on the drug is the only way to keep the weight off
How We Can Help Weight loss is a complex journey, and having a healthcare provider by your side can greatly enhance your success
But like all anabolics and peptides, its value comes down to smart, informed, and responsible use